Select Page
Event info
Date:07 Sep
Time:8:00 - 17:00
Venue:Medicon Village, Lund
Contact person
Mia Ritterband-Rosenbaum

Mia Ritterband-Rosenbaum

Event Manager & PA to CEO

+45 21 63 38 88

The Future of Swedish & Danish Life Science

Welcome to the 11th edition of The Future of Swedish & Danish Life Science
– Opportunities in innovation, funding and growth

The annual international partnering-event The Future of Swedish & Danish Life Science started in 2012 and includes a combination of presentations, access to partnering meetings (pre-bookable one-on-one meetings) as well as informal networking. These four core elements of the day run in parallel and ensure that the event is a lively, energetic day designed to impart new knowledge and build new networks.

The purpose of the event is to find out what Swedish and Danish Life Science can learn from each other and to create new important collaborations.

The event attracts 400-500 leading decision makers every year from all over the world. The participants come from the pharma, biotech and medtech sectors, from the academic research and the healtchcare sector as well as from policy makers, regulatory authorities and the financial services sector.

Date: September 7th 2022
Venue: Medicon Village, Lund, Sweden

The event is free of charge for all delegates




  • How has Danish and Swedish life science evolved over the past ten years?
  • What lies ahead, and how can the life science sector in both countries be
    competitive in the coming decade?
  • What framework conditions, skills and competencies, and type of partnerships
    would we need in order to succeed?

Those are some of the questions we will cover during the 11th edition of The Future of Swedish & Danish Life Science.


08:00 Registration and breakfast
08:30 Welcome and introduction
Samuel Lagercrantz, Editor in chief Life science Sweden
08:35 Medicon Village – 10 years of co-creation and cooperation to advance life science
Petter Hartman, CEO Medicon Village Innovation
08:45 25 years of Swedish-Danish life science collaboration 
Anette Steenberg, CEO Medicon Valley Alliance
08:55 Nasdaq Bell Ringing Ceremony 
Håkan Sjögren, Managing Director, Responsible for Listings, Nasdaq Stockholm
09:00 A Golden Age for Nordic Life Science and how to keep the momentum
Søren Nedergaard, COO The Novo Nordisk Foundation
09:20 Building IP strategies to secure investment
Tom Harding, Patent Attorney Potter Clarkson LLP
09:40 Coffee Break
10:40 The Nordic Life Science Ecosystem – Rationale for local Venture Funds
Tobias Horneman-Thielcke, Founding Partner Eir Ventures
11:00 How to accelerate Scandinavian life science company funding
Johan Kördel, Ph.D. Assoc Prof. Founding
11:20 Research and Drug development – not the same game
Maria Lundberg, CEO, SDS Life Science
Anna Törner, Business Director, SDS Life Science
11:40 Focus on accelerating the growth of the biotech to ensure sustainable future across life science
Bassem Saleh, CEO TFS HealthScience
12:00 Why and how to work with specific areas of high unmet needs such as Womens Health 
Johanna Roostalu, Women’s Health Program Lead/Senior Scientific Developer, BioInnovation Institute
12:20 Find scientific expertise anywhere in the world 
Francesco Ruospo, CBO AcademicLabs
12:25 Lunch 
13:25 Leading in science and innovating for patients 
Christina Lloyd, Senior Vice President , Reproductive Medicine & Maternal Health Ferring Pharmaceuticals
13:45 The furture is now – achieving sustainabillity in the life science business
Martina Kvist Reimer, Executive VP and co-owner Red Glead Discovery
14:05 Cell and gene Therapy – Patience, Potentials, Pitfalls and Patients
Eva-Karin Gidlund, Head of Alliance and Innovation Management NorthX Biologics
14:25 Private-Public partnerships to lead the way in chronic diseases
Niels Abel Bonde, CEO Novo Nordisk Scandinavia AB
14:45 Coffee Break 
15:25 How we enable organ printing
Héctor Martínez,, CTO BICO partner of Sound Bioventures
15:45 Get to know NOME, an elite Nordic Mentoring Program for promising life science startups
Peter Birk, Head of Business Development Accelerace
Hanna Sjöström, CEO GPX Medical
Carl Borrebeack, Professor Department of Immunotechnology
16:00 How VR can deeply improve operators training and therefore mitigate batch failures in the industry 
Pascal Lefebvre, Regional Marketing Manager, Pall Corporation
16:20 Nordic’s Piece in the Global Pharma Innovation Puzzle
Duncan Emerton, Executive Director, Custom Intelligence & Analytics (EMEAI), Pharma Intelligence
16:40 Panel discussion; What to consider before an IPO
Anki Malmborg Hager, Business coach, SmiLe Life Science Incubator
Hanna Sjöström, CEO, Neola Medical
Håkan Sjögren, Managing Director, Responsible for Listings, Nasdaq Stockholm
Okee Williams, Corporate advisory, Redeye
16:30 Summary and conclusion 
17:05 Science After work
Arranged by Medicon Village and Miltenyi Biotech featuring interview with Xintela’s CEO Evy Lundgren-åkerlund 17:20 – 17:30



More information about the speakers can be found at Speakers & Papers – The Future of Swedish & Danish Life Science 2022 (



Organized by In collaboration with